Global medtech announces 7.6% rise in profits
Smith+Nephew has announced full-year trading profits of $970m (£764m), a rise of 7.6%, on the back of a 7.2% rise in underlying revenues.
The global medtech said underlying growth in its orthopaedics division was 5.7%, advanced wound management was up 6.4%, and sports medicine and ENT were up 10% despite headwinds from a slow China market.
Underlying revenues were up from $5.2bn (£4.1bn) to $5.5bn (£4.3bn). It announced a full-year dividend of 37.5c a share, matching last year's dividend.
The firm said its acquisition of ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
